Literature DB >> 24681024

Multidisciplinary approach to the treatment of cardiac AA amyloidosis and aortic stenosis due to Castleman's disease: a hybrid therapy with tocilizumab and aortic valve replacement.

Kohsuke Shirakawa1, Toru Egashira2, Masaki Ieda1, Shinji Kawaguchi3, Kazuma Okamoto3, Mikihiko Kudo3, Kenji Yokoyama4, Hikaru Tsuruta1, Mitsushige Murata1, Shuji Mikami5, Atsushi Anzai1, Kentaro Hayashida1, Takashi Kohno1, Yuichiro Maekawa1, Motoaki Sano1, Ryohei Yozu3, Keiichi Fukuda1.   

Abstract

Entities:  

Keywords:  Aortic stenosis; Cardiac AA amyloidosis; Castleman's disease; Surgical aortic valve replacement; Tocilizumab

Mesh：

Substances：

Year:  2014        PMID： 24681024     DOI： 10.1016/j.ijcard.2014.03.054

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Retroperitoneal unicentric Castleman's disease-a hyaline vascular challenge.

Authors:  Archer Kilbourne Martin; John A Stauffer
Journal:  J Gastrointest Surg       Date:  2014-08-14       Impact factor: 3.452

Review 2.  Update and new approaches in the treatment of Castleman disease.

Authors:  Kah-Lok Chan; Stephen Lade; H Miles Prince; Simon J Harrison
Journal:  J Blood Med       Date:  2016-08-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.